BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 25109255)

  • 1. Lead discovery and optimization strategies for peptide macrocycles.
    Bhat A; Roberts LR; Dwyer JJ
    Eur J Med Chem; 2015 Apr; 94():471-9. PubMed ID: 25109255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrocycles are great cycles: applications, opportunities, and challenges of synthetic macrocycles in drug discovery.
    Marsault E; Peterson ML
    J Med Chem; 2011 Apr; 54(7):1961-2004. PubMed ID: 21381769
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeting "Undruggable" Proteins: Design of Synthetic Cyclopeptides.
    Russo A; Aiello C; Grieco P; Marasco D
    Curr Med Chem; 2016; 23(8):748-62. PubMed ID: 26758797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging strategies to access peptide macrocycles from genetically encoded polypeptides.
    Smith JM; Frost JR; Fasan R
    J Org Chem; 2013 Apr; 78(8):3525-31. PubMed ID: 23517465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrocyclization strategy for improving candidate profiles in medicinal chemistry.
    Darlami O; Pun R; Ahn SH; Kim SH; Shin D
    Eur J Med Chem; 2024 Jun; 272():116501. PubMed ID: 38754142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery: tools and rules for macrocycles.
    Heinis C
    Nat Chem Biol; 2014 Sep; 10(9):696-8. PubMed ID: 25038789
    [No Abstract]   [Full Text] [Related]  

  • 7. Butelase-Mediated Macrocyclization of d-Amino-Acid-Containing Peptides.
    Nguyen GK; Hemu X; Quek JP; Tam JP
    Angew Chem Int Ed Engl; 2016 Oct; 55(41):12802-6. PubMed ID: 27624217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein epitope mimetic macrocycles as biopharmaceuticals.
    Luther A; Moehle K; Chevalier E; Dale G; Obrecht D
    Curr Opin Chem Biol; 2017 Jun; 38():45-51. PubMed ID: 28319811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro selection of multiple libraries created by genetic code reprogramming to discover macrocyclic peptides that antagonize VEGFR2 activity in living cells.
    Kawakami T; Ishizawa T; Fujino T; Reid PC; Suga H; Murakami H
    ACS Chem Biol; 2013; 8(6):1205-14. PubMed ID: 23517428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modular Synthesis of Diverse Natural Product-Like Macrocycles: Discovery of Hits with Antimycobacterial Activity.
    Dow M; Marchetti F; Abrahams KA; Vaz L; Besra GS; Warriner S; Nelson A
    Chemistry; 2017 May; 23(30):7207-7211. PubMed ID: 28374952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of computational design in peptide macrocycle drug discovery.
    Mulligan VK
    Expert Opin Drug Discov; 2020 Jul; 15(7):833-852. PubMed ID: 32345066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative α,ω-diyne coupling as an approach towards novel peptidic macrocycles.
    Verlinden S; Geudens N; Martins JC; Tourwé D; Ballet S; Verniest G
    Org Biomol Chem; 2015 Sep; 13(36):9398-404. PubMed ID: 26246017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Properties and Recent Application of Macrocycles in Medicinal Chemistry.
    Ermert P
    Chimia (Aarau); 2017 Oct; 71(10):678-702. PubMed ID: 29070413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile synthesis of dithiatetraaza-macrocycles of potential anti-inflammatory activity.
    Girgis AS
    Eur J Med Chem; 2008 Oct; 43(10):2116-21. PubMed ID: 18242783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Trends in Macrocyclic Drug Discovery and beyond-Ro5.
    Alihodžić S; Bukvić M; Elenkov IJ; Hutinec A; Koštrun S; Pešić D; Saxty G; Tomašković L; Žiher D
    Prog Med Chem; 2018; 57(1):113-233. PubMed ID: 29680148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformationally based design of macrocycles as antitumor agents.
    Singh EK; Sellers RP; Alexander LD; McAlpine SR
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):544-52. PubMed ID: 18600570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterocycles: Versatile control elements in bioactive macrocycles.
    Soor HS; Appavoo SD; Yudin AK
    Bioorg Med Chem; 2018 Jun; 26(10):2774-2779. PubMed ID: 29735427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of macrocyclic organo-peptide hybrids from ribosomal polypeptide precursors via CuAAC-/hydrazide-mediated cyclization.
    Smith JM; Fasan R
    Methods Mol Biol; 2015; 1248():23-38. PubMed ID: 25616323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of peptide-based macrocyclic cyclophilin inhibitors.
    Granger BA; Brown DG
    Bioorg Med Chem Lett; 2016 Nov; 26(21):5304-5307. PubMed ID: 27687672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and optimization of peptide macrocycles.
    White AM; Craik DJ
    Expert Opin Drug Discov; 2016 Dec; 11(12):1151-1163. PubMed ID: 27718641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.